| SCILEX HLDG CO. O.N. |
| USA |
| US80880W2052 / A412WV |
| D8B0 (Frankfurt) / SCLX (NASDAQ) |
| FRA:D8B0, ETR:D8B0, D8B0:GR, NASDAQ:SCLX |
| - |
| - |
|
Scilex Holding Company is an innovative biopharmaceutical firm focused on acquiring, developing, and commercializing non-opioid pain management products for acute and chronic pain treatment. Its portfolio features ZTLido, a proprietary patch with adv..
>Volltext.. |
| 76.65 Mio. EUR |
| 176.98 Mio. EUR |
| 25.81 Mio. EUR |
| -228.39 Mio. EUR |
| -343.4 Mio. EUR |
| -31.19 EUR |
| 113.09 Mio. EUR |
| 4.23 Mio. EUR |
| 3.28 Mio. EUR |
| 0.02 |
| -46.54% |
| -452.81% |
| - |
| - |
| - |
| - |
| 05.05.26 |
|